Ledger.Open graph →
SEC Form D · Amendment · filed October 31, 2013

CTI SCIENCE, INC

Offering
$5.0M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LEXINGTON, KY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Kittu Kolluri · SUNNYVALE, CAExec · DirectorMark Hale · London, United KingdomExec · Director · PromoterIan J. Ross · Fort Lee, NJExec · Director · PromoterAndrew Burgess · London, United KingdomExec · DirectorJasper Ridge Partners, LP · Fort Worth, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗